AAAAAA
Results:
1-9
|
Results: 9
Authors:
Ferrero-Pous, M
Hersant, AM
Pecking, A
Bresard-Leroy, M
Pichon, MF
Citation: M. Ferrero-pous et al., Serum chromogranin-A in advanced prostate cancer, BJU INT, 88(7), 2001, pp. 790-796
Authors:
Banal, A
Hacene, K
Berthelot-Ruff, E
Mahe, E
Fontana, X
Pichon, MF
Citation: A. Banal et al., Comparison of Cyfra 21-1 and SCC assays in head and neck tumours, TUMOR BIOL, 22(1), 2001, pp. 27-35
Authors:
Blanchet, P
Droupy, S
Eschwege, P
Viellefond, A
Paradis, V
Pichon, MF
Jardin, A
Benoit, G
Citation: P. Blanchet et al., Prospective evaluation of Ki-67 labeling in predicting the recurrence and progression of superficial bladder transitional cell carcinoma, EUR UROL, 40(2), 2001, pp. 169-175
Authors:
Pichon, MF
Basuyau, JP
Gory-Delabaere, G
Eche, N
Daver, A
Blanc-Vincent, MP
Riedinger, JM
Deneux, L
Bidart, JM
Citation: Mf. Pichon et al., Standards, Options and Recommendations for tumor markers in thyroid cancers, B CANCER, 88(8), 2001, pp. 775-792
Authors:
Callet, N
Delaunay, J
Pichon, MF
Citation: N. Callet et al., Serum sICAM-1 (soluble intercellular adhesion molecule-1) and M-CSF (macrophage colony-stimulating growth factor) throughout monitoring of 34 non-serous ovarian cancers, EUR J GYN O, 21(2), 2000, pp. 135-140
Authors:
Pecking, AP
Mechelany-Corone, C
Pichon, MF
Citation: Ap. Pecking et al., 1959-1999: from blood tumour markers to 18-FDG in oncology. Centre Rene-Huguenin's experience., PATH BIOL, 48(9), 2000, pp. 819-824
Authors:
Pichon, MF
Moulin, G
Pallud, C
Pecking, A
Floiras, JL
Citation: Mf. Pichon et al., Serum bFGF (basic fibroblast growth factor) and CA 15.3 in the monitoring of breast cancer patients, ANTICANC R, 20(2B), 2000, pp. 1189-1194
Authors:
Basuyau, JP
Blanc-Vincent, MP
Bidart, JM
Daver, A
Deneux, L
Eche, N
Gory-Delabaere, G
Pichon, MF
Riedinger, JM
Citation: Jp. Basuyau et al., Standards, Options and Recommendations (SOR) for tumor markers in breast cancer, B CANCER, 87(10), 2000, pp. 723-737
Authors:
Pichon, MF
Coquin, G
Fauveau, C
Rey, A
Citation: Mf. Pichon et al., Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors, ANTICANC R, 19(2B), 1999, pp. 1445-1450
Risultati:
1-9
|